InMed Pharmaceuticals Inc. Quarterly Revenues in USD from Q4 2021 to Q4 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary: InMed Pharmaceuticals Inc. quarterly/annual Revenues history and growth rate from Q4 2021 to Q4 2023.
InMed Pharmaceuticals Inc. Revenues for the quarter ending December 31, 2023 was $1.24M, a 164% increase year-over-year.
InMed Pharmaceuticals Inc. Revenues for the twelve months ending December 31, 2023 was $5.49M.
InMed Pharmaceuticals Inc. annual Revenues for 2023 was $4.14M, a 280% increase from 2022.

Revenues, Trailing 12 Months (USD)

Revenues, Quarterly (USD)

Revenues, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q4 2023	$5.49M	$1.24M	+$770K	+164%	Oct 1, 2023	Dec 31, 2023	10-Q	2024-02-13
Q3 2023	$4.72M	$902K	+$581K	+181%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-14
Q2 2023	$4.14M	$2.31M			Apr 1, 2023	Jun 30, 2023	10-K	2023-09-29
Q1 2023		$1.03M	+$724K	+234%	Jan 1, 2023	Mar 31, 2023	10-Q	2023-05-15
Q4 2022		$470K	+$205K	+77.2%	Oct 1, 2022	Dec 31, 2022	10-Q	2024-02-13
Q3 2022		$321K			Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-14
Q1 2022		$310K			Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-15
Q4 2021		$265K			Oct 1, 2021	Dec 31, 2021	10-Q	2023-02-17

* An asterisk sign (*) next to the value indicates that the value is likely invalid.